avrg: GSE58827: Dynamics of the Mouse Liver
Gene Symbol | Gene ID | Gene Info |
---|---|---|
Hdx
|
ENSMUSG00000034551.6 | highly divergent homeobox |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Hdx | mm10_v2_chrX_-_111697069_111697127 | -0.56 | 4.0e-04 | Click! |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
9.0 | 45.1 | GO:0001970 | positive regulation of activation of membrane attack complex(GO:0001970) |
3.8 | 42.3 | GO:0071394 | cellular response to testosterone stimulus(GO:0071394) |
2.3 | 13.6 | GO:0038161 | prolactin signaling pathway(GO:0038161) |
1.1 | 6.4 | GO:0006068 | ethanol catabolic process(GO:0006068) |
1.0 | 3.1 | GO:2000295 | regulation of hydrogen peroxide catabolic process(GO:2000295) |
1.0 | 8.7 | GO:0045919 | positive regulation of cytolysis(GO:0045919) |
0.9 | 2.7 | GO:0090297 | positive regulation of mitochondrial DNA replication(GO:0090297) regulation of cardiolipin metabolic process(GO:1900208) positive regulation of cardiolipin metabolic process(GO:1900210) stress-induced mitochondrial fusion(GO:1990046) |
0.9 | 6.0 | GO:0042905 | 9-cis-retinoic acid biosynthetic process(GO:0042904) 9-cis-retinoic acid metabolic process(GO:0042905) |
0.8 | 3.3 | GO:0015851 | nucleobase transport(GO:0015851) pyrimidine nucleobase transport(GO:0015855) |
0.8 | 3.2 | GO:0006166 | purine ribonucleoside salvage(GO:0006166) |
0.8 | 2.3 | GO:0002426 | immunoglobulin production in mucosal tissue(GO:0002426) |
0.7 | 4.1 | GO:0035166 | post-embryonic hemopoiesis(GO:0035166) |
0.7 | 2.0 | GO:0036509 | trimming of terminal mannose on B branch(GO:0036509) positive regulation of retrograde protein transport, ER to cytosol(GO:1904154) |
0.6 | 1.9 | GO:1902605 | heterotrimeric G-protein complex assembly(GO:1902605) |
0.6 | 4.8 | GO:0042126 | nitrate metabolic process(GO:0042126) |
0.5 | 2.2 | GO:0046381 | CMP-N-acetylneuraminate metabolic process(GO:0046381) |
0.5 | 9.2 | GO:0042448 | progesterone metabolic process(GO:0042448) |
0.5 | 7.5 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
0.5 | 5.9 | GO:0009812 | flavonoid metabolic process(GO:0009812) |
0.4 | 3.0 | GO:0006621 | protein retention in ER lumen(GO:0006621) |
0.4 | 2.1 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
0.4 | 0.4 | GO:2000259 | positive regulation of complement activation(GO:0045917) positive regulation of protein activation cascade(GO:2000259) |
0.4 | 3.9 | GO:1901621 | negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901621) |
0.3 | 3.1 | GO:0009301 | snRNA transcription(GO:0009301) |
0.3 | 0.6 | GO:1901420 | negative regulation of response to alcohol(GO:1901420) |
0.3 | 2.0 | GO:0032790 | ribosome disassembly(GO:0032790) |
0.3 | 2.0 | GO:0061087 | positive regulation of histone H3-K27 methylation(GO:0061087) |
0.3 | 4.8 | GO:0046069 | cGMP catabolic process(GO:0046069) |
0.2 | 1.0 | GO:0007262 | STAT protein import into nucleus(GO:0007262) |
0.2 | 3.1 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
0.2 | 1.0 | GO:0018364 | peptidyl-glutamine methylation(GO:0018364) |
0.2 | 3.6 | GO:0021684 | cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
0.2 | 1.7 | GO:0060164 | regulation of timing of neuron differentiation(GO:0060164) |
0.2 | 0.6 | GO:0034395 | regulation of transcription from RNA polymerase II promoter in response to iron(GO:0034395) |
0.2 | 4.5 | GO:0001886 | endothelial cell morphogenesis(GO:0001886) |
0.2 | 3.6 | GO:0072189 | ureter development(GO:0072189) |
0.2 | 2.9 | GO:0071447 | cellular response to hydroperoxide(GO:0071447) |
0.2 | 0.8 | GO:0070318 | positive regulation of G0 to G1 transition(GO:0070318) regulation of vitamin D receptor signaling pathway(GO:0070562) |
0.1 | 0.9 | GO:1901674 | histone H3-K27 acetylation(GO:0043974) leukemia inhibitory factor signaling pathway(GO:0048861) positive regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis(GO:0072108) regulation of histone H3-K27 acetylation(GO:1901674) |
0.1 | 1.3 | GO:0016093 | polyprenol metabolic process(GO:0016093) |
0.1 | 7.6 | GO:0006956 | complement activation(GO:0006956) |
0.1 | 3.6 | GO:0033622 | integrin activation(GO:0033622) |
0.1 | 2.6 | GO:0034063 | stress granule assembly(GO:0034063) |
0.1 | 4.4 | GO:0048147 | negative regulation of fibroblast proliferation(GO:0048147) |
0.1 | 1.3 | GO:0002862 | negative regulation of inflammatory response to antigenic stimulus(GO:0002862) |
0.1 | 2.7 | GO:0040023 | nuclear migration(GO:0007097) establishment of nucleus localization(GO:0040023) |
0.1 | 2.1 | GO:1902857 | positive regulation of nonmotile primary cilium assembly(GO:1902857) |
0.1 | 13.0 | GO:0007586 | digestion(GO:0007586) |
0.1 | 0.4 | GO:1900170 | negative regulation of glucocorticoid mediated signaling pathway(GO:1900170) |
0.1 | 2.1 | GO:0031571 | mitotic G1 DNA damage checkpoint(GO:0031571) |
0.1 | 2.2 | GO:0010763 | positive regulation of fibroblast migration(GO:0010763) |
0.1 | 0.2 | GO:0070343 | white fat cell proliferation(GO:0070343) regulation of white fat cell proliferation(GO:0070350) |
0.1 | 1.1 | GO:1904262 | negative regulation of TORC1 signaling(GO:1904262) |
0.1 | 0.8 | GO:0098719 | sodium ion import(GO:0097369) sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
0.1 | 0.9 | GO:0060330 | regulation of response to interferon-gamma(GO:0060330) |
0.1 | 3.4 | GO:0010501 | RNA secondary structure unwinding(GO:0010501) |
0.0 | 0.7 | GO:0010566 | regulation of ketone biosynthetic process(GO:0010566) |
0.0 | 0.5 | GO:0060272 | embryonic skeletal joint morphogenesis(GO:0060272) |
0.0 | 0.2 | GO:0046010 | positive regulation of circadian sleep/wake cycle, non-REM sleep(GO:0046010) |
0.0 | 8.1 | GO:0007596 | blood coagulation(GO:0007596) |
0.0 | 2.2 | GO:0006940 | regulation of smooth muscle contraction(GO:0006940) |
0.0 | 0.9 | GO:0060009 | Sertoli cell development(GO:0060009) |
0.0 | 2.1 | GO:0038083 | peptidyl-tyrosine autophosphorylation(GO:0038083) |
0.0 | 0.3 | GO:0042427 | serotonin biosynthetic process(GO:0042427) primary amino compound biosynthetic process(GO:1901162) |
0.0 | 0.4 | GO:0032780 | negative regulation of ATPase activity(GO:0032780) |
0.0 | 1.0 | GO:0010758 | regulation of macrophage chemotaxis(GO:0010758) |
0.0 | 1.8 | GO:0048806 | genitalia development(GO:0048806) |
0.0 | 5.2 | GO:0030178 | negative regulation of Wnt signaling pathway(GO:0030178) |
0.0 | 1.5 | GO:0021884 | forebrain neuron development(GO:0021884) |
0.0 | 1.6 | GO:0055013 | cardiac muscle cell development(GO:0055013) |
0.0 | 0.1 | GO:0035063 | nuclear speck organization(GO:0035063) |
0.0 | 0.3 | GO:0098789 | pre-mRNA cleavage required for polyadenylation(GO:0098789) |
0.0 | 3.1 | GO:0016579 | protein deubiquitination(GO:0016579) |
0.0 | 2.6 | GO:0007098 | centrosome cycle(GO:0007098) |
0.0 | 1.1 | GO:0050907 | detection of chemical stimulus involved in sensory perception(GO:0050907) |
0.0 | 1.5 | GO:0046426 | negative regulation of JAK-STAT cascade(GO:0046426) negative regulation of STAT cascade(GO:1904893) |
0.0 | 4.2 | GO:0031032 | actomyosin structure organization(GO:0031032) |
0.0 | 0.2 | GO:0019430 | removal of superoxide radicals(GO:0019430) |
0.0 | 1.1 | GO:0006367 | transcription initiation from RNA polymerase II promoter(GO:0006367) |
0.0 | 0.2 | GO:0045086 | positive regulation of interleukin-2 biosynthetic process(GO:0045086) |
0.0 | 0.8 | GO:0050982 | detection of mechanical stimulus(GO:0050982) |
0.0 | 0.1 | GO:2000653 | regulation of genetic imprinting(GO:2000653) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.1 | 45.1 | GO:0005579 | membrane attack complex(GO:0005579) |
0.7 | 4.1 | GO:0032437 | cuticular plate(GO:0032437) |
0.6 | 3.1 | GO:0031838 | haptoglobin-hemoglobin complex(GO:0031838) |
0.4 | 3.0 | GO:0000836 | ER ubiquitin ligase complex(GO:0000835) Hrd1p ubiquitin ligase complex(GO:0000836) |
0.3 | 3.9 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.3 | 1.5 | GO:0001674 | female germ cell nucleus(GO:0001674) |
0.3 | 7.6 | GO:0044215 | other organism(GO:0044215) other organism cell(GO:0044216) other organism part(GO:0044217) |
0.2 | 2.2 | GO:0030478 | actin cap(GO:0030478) |
0.2 | 1.1 | GO:1990130 | Iml1 complex(GO:1990130) |
0.2 | 2.0 | GO:0001739 | sex chromatin(GO:0001739) |
0.2 | 0.6 | GO:0032010 | phagolysosome(GO:0032010) |
0.2 | 1.1 | GO:0097550 | transcriptional preinitiation complex(GO:0097550) |
0.2 | 2.1 | GO:1990635 | proximal dendrite(GO:1990635) |
0.1 | 1.0 | GO:0031428 | box C/D snoRNP complex(GO:0031428) |
0.1 | 2.1 | GO:0031105 | septin complex(GO:0031105) |
0.1 | 0.4 | GO:0001405 | presequence translocase-associated import motor(GO:0001405) |
0.1 | 2.6 | GO:0016581 | NuRD complex(GO:0016581) CHD-type complex(GO:0090545) |
0.1 | 2.7 | GO:0042101 | T cell receptor complex(GO:0042101) |
0.1 | 3.1 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.1 | 8.7 | GO:0072562 | blood microparticle(GO:0072562) |
0.1 | 3.6 | GO:0031941 | filamentous actin(GO:0031941) |
0.1 | 0.4 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
0.0 | 4.4 | GO:0005581 | collagen trimer(GO:0005581) |
0.0 | 0.5 | GO:0031464 | Cul2-RING ubiquitin ligase complex(GO:0031462) Cul4A-RING E3 ubiquitin ligase complex(GO:0031464) |
0.0 | 2.6 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
0.0 | 6.0 | GO:0030176 | integral component of endoplasmic reticulum membrane(GO:0030176) |
0.0 | 3.4 | GO:0030864 | cortical actin cytoskeleton(GO:0030864) |
0.0 | 0.7 | GO:0030285 | integral component of synaptic vesicle membrane(GO:0030285) intrinsic component of synaptic vesicle membrane(GO:0098563) |
0.0 | 0.4 | GO:0031315 | extrinsic component of mitochondrial outer membrane(GO:0031315) |
0.0 | 4.0 | GO:0043204 | perikaryon(GO:0043204) |
0.0 | 4.8 | GO:0005741 | mitochondrial outer membrane(GO:0005741) |
0.0 | 0.2 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
0.0 | 0.8 | GO:0016592 | mediator complex(GO:0016592) |
0.0 | 2.2 | GO:0016591 | DNA-directed RNA polymerase II, holoenzyme(GO:0016591) |
0.0 | 2.7 | GO:0044798 | nuclear transcription factor complex(GO:0044798) |
0.0 | 0.2 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
0.0 | 7.6 | GO:0031012 | extracellular matrix(GO:0031012) |
0.0 | 0.3 | GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex(GO:0005847) |
0.0 | 0.6 | GO:0032420 | stereocilium(GO:0032420) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.7 | 13.6 | GO:0004925 | prolactin receptor activity(GO:0004925) |
1.6 | 4.8 | GO:0008940 | nitrate reductase activity(GO:0008940) |
1.3 | 9.0 | GO:0001851 | complement component C3b binding(GO:0001851) |
1.3 | 6.4 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
1.1 | 3.2 | GO:0004731 | purine-nucleoside phosphorylase activity(GO:0004731) |
1.0 | 6.0 | GO:0047035 | alcohol dehydrogenase (NAD) activity(GO:0004022) testosterone dehydrogenase (NAD+) activity(GO:0047035) |
1.0 | 7.6 | GO:0001849 | complement component C1q binding(GO:0001849) |
0.7 | 2.2 | GO:0030338 | CMP-N-acetylneuraminate monooxygenase activity(GO:0030338) |
0.7 | 2.1 | GO:0001888 | glucuronyl-galactosyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0001888) |
0.7 | 3.3 | GO:0015254 | purine nucleobase transmembrane transporter activity(GO:0005345) pyrimidine nucleobase transmembrane transporter activity(GO:0005350) nucleobase transmembrane transporter activity(GO:0015205) glycerol channel activity(GO:0015254) |
0.6 | 9.2 | GO:0016832 | aldehyde-lyase activity(GO:0016832) |
0.6 | 21.2 | GO:0015020 | glucuronosyltransferase activity(GO:0015020) |
0.5 | 7.5 | GO:0022841 | potassium ion leak channel activity(GO:0022841) |
0.4 | 3.1 | GO:0030492 | hemoglobin binding(GO:0030492) |
0.4 | 3.9 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
0.3 | 3.1 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
0.3 | 1.9 | GO:0017040 | ceramidase activity(GO:0017040) |
0.3 | 2.7 | GO:1901612 | cardiolipin binding(GO:1901612) |
0.3 | 2.0 | GO:0046976 | histone methyltransferase activity (H3-K27 specific)(GO:0046976) |
0.2 | 1.9 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
0.2 | 2.0 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
0.2 | 0.9 | GO:0005146 | leukemia inhibitory factor receptor binding(GO:0005146) |
0.2 | 4.8 | GO:0047555 | 3',5'-cyclic-GMP phosphodiesterase activity(GO:0047555) |
0.2 | 0.8 | GO:0036033 | mediator complex binding(GO:0036033) |
0.2 | 4.9 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.2 | 0.5 | GO:0005171 | hepatocyte growth factor receptor binding(GO:0005171) |
0.2 | 1.2 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
0.2 | 2.0 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
0.1 | 5.7 | GO:0005044 | scavenger receptor activity(GO:0005044) |
0.1 | 2.2 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
0.1 | 2.9 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
0.1 | 0.4 | GO:0038049 | glucocorticoid receptor activity(GO:0004883) transcription factor activity, ligand-activated RNA polymerase II transcription factor binding(GO:0038049) glucocorticoid-activated RNA polymerase II transcription factor binding transcription factor activity(GO:0038051) |
0.1 | 1.3 | GO:0004659 | prenyltransferase activity(GO:0004659) |
0.1 | 4.8 | GO:0003743 | translation initiation factor activity(GO:0003743) |
0.1 | 0.8 | GO:0015386 | potassium:proton antiporter activity(GO:0015386) |
0.1 | 2.1 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.1 | 0.3 | GO:0004510 | tryptophan 5-monooxygenase activity(GO:0004510) |
0.1 | 10.0 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.1 | 1.0 | GO:0008649 | rRNA methyltransferase activity(GO:0008649) |
0.1 | 3.6 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
0.1 | 0.2 | GO:0016608 | growth hormone-releasing hormone activity(GO:0016608) |
0.1 | 0.3 | GO:0050265 | RNA uridylyltransferase activity(GO:0050265) |
0.1 | 2.3 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
0.1 | 2.6 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.1 | 0.4 | GO:0004689 | phosphorylase kinase activity(GO:0004689) |
0.0 | 0.5 | GO:0005041 | low-density lipoprotein receptor activity(GO:0005041) |
0.0 | 1.0 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.0 | 0.7 | GO:0070403 | NAD+ binding(GO:0070403) |
0.0 | 4.2 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
0.0 | 2.1 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.0 | 3.1 | GO:0036459 | thiol-dependent ubiquitinyl hydrolase activity(GO:0036459) ubiquitinyl hydrolase activity(GO:0101005) |
0.0 | 2.8 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.0 | 4.1 | GO:0003774 | motor activity(GO:0003774) |
0.0 | 2.9 | GO:0005057 | receptor signaling protein activity(GO:0005057) |
0.0 | 0.8 | GO:0004722 | protein serine/threonine phosphatase activity(GO:0004722) |
0.0 | 1.5 | GO:0004860 | protein kinase inhibitor activity(GO:0004860) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 14.5 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
0.1 | 3.9 | PID IL3 PATHWAY | IL3-mediated signaling events |
0.1 | 3.0 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.1 | 2.6 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.1 | 2.9 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.1 | 2.2 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.1 | 3.6 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.1 | 5.2 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.1 | 2.3 | PID CDC42 PATHWAY | CDC42 signaling events |
0.0 | 5.2 | PID CMYB PATHWAY | C-MYB transcription factor network |
0.0 | 3.2 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
0.0 | 1.5 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.0 | 3.2 | PID ERBB1 DOWNSTREAM PATHWAY | ErbB1 downstream signaling |
0.0 | 0.8 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.0 | 0.6 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.6 | 53.7 | REACTOME COMPLEMENT CASCADE | Genes involved in Complement cascade |
0.7 | 9.2 | REACTOME ENDOGENOUS STEROLS | Genes involved in Endogenous sterols |
0.7 | 13.6 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
0.6 | 7.5 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.5 | 6.4 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.5 | 5.9 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.3 | 3.3 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
0.2 | 2.9 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.2 | 3.2 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
0.2 | 2.0 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
0.2 | 4.6 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
0.2 | 3.9 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.1 | 4.8 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
0.1 | 1.3 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors |
0.1 | 2.2 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.0 | 1.9 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
0.0 | 2.2 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.0 | 1.0 | REACTOME SHC1 EVENTS IN EGFR SIGNALING | Genes involved in SHC1 events in EGFR signaling |
0.0 | 4.6 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
0.0 | 1.1 | REACTOME RNA POL II TRANSCRIPTION PRE INITIATION AND PROMOTER OPENING | Genes involved in RNA Polymerase II Transcription Pre-Initiation And Promoter Opening |
0.0 | 2.3 | REACTOME REGULATION OF MRNA STABILITY BY PROTEINS THAT BIND AU RICH ELEMENTS | Genes involved in Regulation of mRNA Stability by Proteins that Bind AU-rich Elements |
0.0 | 2.1 | REACTOME SIGNALING BY SCF KIT | Genes involved in Signaling by SCF-KIT |
0.0 | 0.4 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.0 | 0.4 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
0.0 | 0.3 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |